Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis

Journal of Bone and Mineral Metabolism

Volumn 29, Issue 4, 2011, Pages 458-465

  Takada, Junichi ^a,b   Katahira, Genichiro ^c   Iba, Kousuke ^a   Yoshizaki, Takashi ^b   Yamashita, Toshihiko ^a  

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b Kitago Orthopedic Clinic   (Japan)

^c Kiyota Hospital   (Japan)

Author keywords

Alendronate; Bisphosphonate; Geometry; Hip structure analysis; Risedronate

Indexed keywords

ALENDRONIC ACID; RISEDRONIC ACID;

AGED; ARTICLE; BONE BOWING; BONE DENSITY; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; DRUG EFFECT; DRUG RESPONSE; FEMALE; HIP; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STRUCTURE ANALYSIS; TREATMENT DURATION;

AGED; ALENDRONATE; ASIAN CONTINENTAL ANCESTRY GROUP; DIPHOSPHONATES; ETIDRONIC ACID; FEMALE; HIP; HUMANS; JAPAN; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 80052453627     PISSN: 09148779     EISSN: 14355604     Source Type: Journal    
DOI: 10.1007/s00774-010-0242-8     Document Type: Article

References (26)

1. Kanis JA (2002) Diagnosis of osteoporosis and assessment of fracture risk. Lancet 359:1929-1936 (Pubitemid 34615775)
2. Miller PD (2003) Bone mass measurements. Clin Geriatr Med 19:281-297 (Pubitemid 36514520)
3. Schott AM, Cormier C, Hans D, Favier F, Hausherr E, Dargent- Molina P, Delmas PD, Ribot C, Sebert JL, Breart G, Meunier PJ, for EPIDOS Group (1998) How hip and whole-body bone mineral density predict hip fracture in elderly women: the EPIDOS Prospective Study. Osteoporos Int 8:247-254 (Pubitemid 28427074)
4. Li Z, Meredith MP, Hoseyni MS (2001) A method to assess the proportion of treatment effect explained by a surrogate endpoint. Stat Med 20:3175-3188 (Pubitemid 33034879)
5. Cummings SR, Karpf DB, Harris F, Genant HK, Ensrud K, LaCroix AZ, Dennis M, Black DM (2002) Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med 112:281-289 (Pubitemid 34219441)
6. Sarkar S, Mitlak BH, Wong M, Stock JL, Black DM, Harper KD (2002) Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy. J Bone Miner Res 17:1-10 (Pubitemid 33150990)
7. Beck TJ, Ruff CB, Warden KE, Scott WW Jr, Rao GU (1990) Predicting femoral neck strength from bone mineral data: a structural approach. Invest Rad 25:6-18 (Pubitemid 20040519)
8. Beck TJ, Ruff CB, Scott WW Jr, Plato CC, Tobin JD, Quan CA (1992) Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data. Calcif Tissue Int 50:24-29
9. Beck TJ, Ruff CB, Bissessur K (1993) Age-related changes in female femoral neck geometry: implications for bone strength. Calcif Tissue Int 53(Suppl 1):S41-S46 (Pubitemid 23277167)
10. Beck TJ, Looker AC, Ruff CB (2000) Structural trends in the aging femoral neck and proximal shaft: analysis of the Third National Health and Nutrition Examination Survey dual-energy X-ray absorptiometry data. J Bone Miner Res 15:2297-2304
11. Wang XF, Duan Y, Beck TJ, Seeman E (2005) Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age. Bone 36:978-986 (Pubitemid 40797998)
12. Uusi-Rasi K, Beck TJ, Semanick LM, Daphtary MM, Crans GG, Desaiah D, Harper KD (2006) Structural effects of raloxifene on the proximal femur: results from the multiple outcomes of raloxifene evaluation trial. Osteoporos Int 17:575-586
13. Greenspan SL, Beck TJ, Resnick NM, Bhattacharya R, Parker RA (2005) Effect of hormone replacement, alendronate, or combination therapy on hip structure geometry: a 3-year, double blind, placebo-controlled clinical trial. J Bone Miner Res 20:1525-1532 (Pubitemid 41243541)
14. Uusi-Rasi K, Semanick LM, Zanchetta JR, Bogado CE, Eriksen EF, Sato M, Beck TJ (2005) Effects of teriparatide [rh PTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women. Bone 36:948-958 (Pubitemid 40797995)
15. Bonnick SL, Beck TJ, Cosman F, Hochberg MC, Wang H, de Papp AE (2009) DXA-based hip structural analysis of onceweekly bisphosphonate-treated postmenopausal women with low bone mass. Osteoporos Int 20:911-921
16. Beck TJ, Lewiecki EM, Miller PD, Felsenberg D, Liu Y, Ding B, Libanati C (2008) Effects of denosumab on the geometry of the proximal femur in postmenopausal women in comparison with alendronate. J Clin Densitom 11:351-359
17. Takada J, Beck TJ, Iba K, Yamashita T (2007) Structural trends in the aging proximal femur in Japanese postmenopausal women. Bone 41:97-102 (Pubitemid 46891904)
18. Takada J, Miki T, Imanishi Y, Nakatsuka K, Wada H, Naka H, Yoshizaki T, Iba K, Beck TJ, Yamashita T (2010) Effects of raloxifene treatment on structural geometry of the proximal femur in Japanese women with osteoporosis. J Bone Miner Metab 28:561-567
19. Ito M, Sone T, Fukunaga M (2010) Effect of minodronic acid hydrate on hip geometry in Japanese women with postmenopausal osteoporosis. J Bone Miner Metab 28:334-341
20. Uchida S, Taniguchi T, Shimizu T, Kakikawa T, Okuyama K, Okaniwa M, Arizono H, Nagata K, Santora AC, Shiraki M, Fukunaga M, Tomomitsu T, Ohashi Y, Nakamura T (2005) Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study. J Bone Miner Metab 23:382-388 (Pubitemid 41223801)
21. Kishimoto H, Fukunaga M, Kushida K, Shiraki M, Itabashi A, Nawata H, Nakamura T, Ohta H, Takaoka K, Ohashi Y, for the Risedronate Phase III Research Group (2006) Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen. J Bone Miner Metab 24:405-413 (Pubitemid 44306178)
22. Osteoporosis diagnostic criteria review committee: Japanese society for bone, mineral research (2001) Diagnostic criteria for primary osteoporosis: year 2000 revision. J Bone Miner Metab 19:331-337
23. Hans D, Duboeuf F, Schott AM, Horn S, Avioli LV, Drezner MK, Meunier PJ (1997) Effects of a new positioner on the precision of hip bone mineral density measurements. J Bone Miner Res 12:1289-1294 (Pubitemid 27334976)
24. Ruff CB, Hayes WC (1983) Cross-sectional geometry of Pecos Pueblo femora and tibiae-a biomechanical investigation. I. Method and general patterns of variation. Am J Phys Anthropol 60:359-381 (Pubitemid 13132324)
25. Melton LJ III, Beck TJ, Amin S, Khosla S, Achenbach SJ, Oberg AL, Riggs BL (2005) Contributions of bone density and structure to fracture risk assessment in men and women. Osteoporos Int 16:460-467
26. Nelson DA, Barondess DA, Hendrix SL, Beck TJ (2000) Crosssectional geometry, bone strength, and bone mass in the proximal femur in black and white postmenopausal women. J Bone Miner Res 15:1992-1997